mFOLFOX6 + bevacizumab + PD-1 monoclonal antibody vs. mFOLFOX6 in locally advanced pMMR/MSS CRC: A multicenter, randomized controlled phase III study (BASKETIII).
Authors: Jun Huang, Ping Liu, Zheng Liu, Wan He, Zhenyu Lin, Chao Dong, Shasha Ruan, Fang He, Yandong Zhao, Zhimin Liu, Fengyun Pei, Qijun Yao, Menghan Wang